Adam Kraya

1.8k total citations
13 papers, 315 citations indexed

About

Adam Kraya is a scholar working on Molecular Biology, Genetics and Dermatology. According to data from OpenAlex, Adam Kraya has authored 13 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Dermatology. Recurrent topics in Adam Kraya's work include Glioma Diagnosis and Treatment (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Dermatology and Skin Diseases (3 papers). Adam Kraya is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Dermatology and Skin Diseases (3 papers). Adam Kraya collaborates with scholars based in United States, Switzerland and Germany. Adam Kraya's co-authors include Bradley Wubbenhorst, Katherine L. Nathanson, Nandita Mitra, Xiaowei Xu, Ravi K. Amaravadi, Shengfu Piao, Kurt D’Andrea, David W. Speicher, Meenhard Herlyn and Phyllis A. Gimotty and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Adam Kraya

11 papers receiving 311 citations

Peers

Countries citing papers authored by Adam Kraya

Since Specialization

Citations

This map shows the geographic impact of Adam Kraya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Kraya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Kraya more than expected).

Fields of papers citing papers by Adam Kraya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Kraya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Kraya. The network helps show where Adam Kraya may publish in the future.

Co-authorship network of co-authors of Adam Kraya

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Kraya. A scholar is included among the top collaborators of Adam Kraya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Kraya. Adam Kraya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome Profiling 2025 ·Cancers ·Adam Kraya, Komal S. Rathi, Run Jin, Varun Kesherwani, Adam Resnick, Phillip B. Storm, Ali Nabavizadeh	0
2	METB-12. GIFT FROM A CHILD POSTMORTEM SPECIMEN DATASET EXTENSION OF THE PEDIATRIC BRAIN TUMOR ATLAS EMPOWERS PEDIATRIC BRAIN TUMOR RESEARCH 2024 ·Neuro-Oncology ·Mateusz Koptyra, (unknown), Jo Lynne Rokita, (unknown), (unknown), (unknown), Adam Kraya, Valérie Baubet, (unknown), Catherine Sullivan, (unknown), (unknown), Jena Lilly, Mariarita Santi, Angela N. Viaene, Phillip B. Storm, Adam Resnick, (unknown)	0
3	IMG-13. PREDICTION OF PEDIATRIC MEDULLOBLASTOMA SUBGROUPS USING CLINICO-RADIOMIC ANALYSIS 2024 ·Neuro-Oncology ·Ariana Familiar, Anahita Fathi Kazerooni, Adam Kraya, Komal S. Rathi, Nastaran Khalili, (unknown), Hannah Anderson, Aria Mahtabfar, Jeffrey B. Ware, Arastoo Vossough, Phillip B. Storm, Adam Resnick, (unknown)	1
4	TRLS-04. EARLY INSIGHTS FROM PNOC027: PERSONALIZED TREATMENT APPROACHES BASED ON REAL-TIME DRUG SCREENING AND GENOMIC TESTING IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RECURRENT MEDULLOBLASTOMA 2024 ·Neuro-Oncology ·(unknown), (unknown), Janel Long-Boyle, (unknown), (unknown), (unknown), (unknown), Lindsay Kilburn, Roger J. Packer, Jennifer Elster, Alyssa Reddy, Carl Koschmann, Adam Kraya, Adam Resnick, Michael D. Prados, Cassie Kline, Sabine Mueller, Robert J. Wechsler‐Reya, Joshua B. Rubin	2
5	Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial 2023 ·Journal of Clinical Oncology ·Daphne A. Haas‐Kogan, Mariam Aboian, Jane E. Minturn, Sarah Leary, Mohamed S Abdelbaki, Stewart Goldman, Jennifer Elster, Adam Kraya, (unknown), (unknown), (unknown), Kevin X. Liu, Jo Lynne Rokita, Adam Resnick, David A. Solomon, Joanna J. Phillips, Michael D. Prados, Annette M. Molinaro, Sebastian M. Waszak, Sabine Mueller	11
6	Radiomics for characterization of the glioma immune microenvironment 2023 ·npj Precision Oncology ·Nastaran Khalili, Anahita Fathi Kazerooni, Ariana Familiar, Debanjan Haldar, Adam Kraya, Jessica Foster, Mateusz Koptyra, Phillip B. Storm, Adam Resnick, Ali Nabavizadeh	25
7	PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer 2022 ·JCO Precision Oncology ·Adam Kraya, Kara N. Maxwell, Monika A. Eiva, Bradley Wubbenhorst, John Pluta, Michael D. Feldman, Anupma Nayak, Daniel J. Powell, Susan M. Domchek, Robert H. Vonderheide, Katherine L. Nathanson	9
8	Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers 2022 ·Nature Communications ·Jennifer Shah, Dana Pueschl, Bradley Wubbenhorst, (unknown), John Pluta, Kurt D’Andrea, (unknown), (unknown), Wenting Zhou, Adam Kraya, (unknown), (unknown), Violeta Serra, Judith Balmañà, Michael D. Feldman, Patrice J. Morin, Anupma Nayak, Kara N. Maxwell, Susan M. Domchek, Katherine L. Nathanson	14
9	Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer 2019 ·Clinical Cancer Research ·Adam Kraya, Kara N. Maxwell, Bradley Wubbenhorst, Brandon M. Wenz, John Pluta, Andrew J. Rech, Liza M. Dorfman, (unknown), (unknown), Nandita Mitra, Jennifer J.D. Morrissette, Michael D. Feldman, Anupma Nayak, Susan M. Domchek, Robert H. Vonderheide, Katherine L. Nathanson	57
10	Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis 2019 ·JAMA Dermatology ·David J. Margolis, Nandita Mitra, Bradley Wubbenhorst, Kurt D’Andrea, Adam Kraya, Ole Hoffstad, (unknown), Katherine L. Nathanson	40
11	Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans 2018 ·Journal of Investigative Dermatology ·David J. Margolis, Nandita Mitra, (unknown), Bradley Wubbenhorst, Kurt D’Andrea, Adam Kraya, Ole Hoffstad, Jayanta Gupta, Brian Kim, Albert C. Yan, Zelma C. Chiesa Fuxench, Katherine L. Nathanson	57
12	259 Uncommon filaggrin variants are associated with persistent atopic dermatitis in African-Americans 2018 ·Journal of Investigative Dermatology ·David J. Margolis, N. K. Mitra, (unknown), Kurt D’Andrea, Adam Kraya, Ole Hoffstad, Katherine L. Nathanson	2
13	Identification of secreted proteins that reflect autophagy dynamics within tumor cells 2014 ·Autophagy ·Adam Kraya, Shengfu Piao, Xiaowei Xu, Gao Zhang, Meenhard Herlyn, Phyllis A. Gimotty, Beth Levine, Ravi K. Amaravadi, David W. Speicher	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact